From the soil to the clinic: the impact of microbial secondary metabolites on antibiotic tolerance and resistance
- 16 September 2021
- journal article
- review article
- Published by Springer Nature in Nature Reviews Microbiology
- Vol. 20 (3) , 129-142
Abstract
Secondary metabolites profoundly affect microbial physiology, metabolism and stress responses. Increasing evidence suggests that these molecules can modulate microbial susceptibility to commonly used antibiotics; however, secondary metabolites are typically excluded from standard antimicrobial susceptibility assays. This may in part account for why infections by diverse opportunistic bacteria that produce secondary metabolites often exhibit discrepancies between clinical antimicrobial susceptibility testing results and clinical treatment outcomes. In this Review, we explore which types of secondary metabolite alter antimicrobial susceptibility, as well as how and why this phenomenon occurs. We discuss examples of molecules that opportunistic and enteric pathogens either generate themselves or are exposed to from their neighbours, and the nuanced impacts these molecules can have on tolerance and resistance to certain antibiotics.Keywords
This publication has 182 references indexed in Scilit:
- Salmonella typhimurium intercepts Escherichia coli signaling to enhance antibiotic toleranceProceedings of the National Academy of Sciences, 2013
- Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosisJournal of Cystic Fibrosis, 2012
- Signaling-mediated bacterial persister formationNature Chemical Biology, 2012
- Global regulation of gene expression by OxyR in an important human opportunistic pathogenNucleic Acids Research, 2012
- The SoxRS response of Escherichia coli is directly activated by redox‐cycling drugs rather than by superoxideMolecular Microbiology, 2011
- Bacterial charity work leads to population-wide resistanceNature, 2010
- Color me bad: microbial pigments as virulence factorsTrends in Microbiology, 2009
- Inhibition of Staphyloxanthin Virulence Factor Biosynthesis in Staphylococcus aureus: In Vitro, in Vivo, and Crystallographic ResultsJournal of Medicinal Chemistry, 2009
- Redox-Active Antibiotics Control Gene Expression and Community Behavior in Divergent BacteriaScience, 2008
- Multidrug-resistance efflux pumps ? not just for resistanceNature Reviews Microbiology, 2006